Results of a phase I clinical study using autologous tumour lysate-pulsed monocyte-derived mature dendritic cell vaccinations for stage IV malignant melanoma patients combined with low dose interleukin-2.

Details

Language :

English

ISSN :

09608931

Volume :

13

Issue :

5

Database :

Complementary Index

Journal :

Melanoma Research

Publication Type :

Academic Journal

Accession number :

10961614

Full Text :

https://doi.org/10.1097/00008390-200310000-00011